These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 19151115)
1. Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study. Falcini F; Capannini S; Martini G; La Torre F; Vitale A; Mangiantini F; Nacci F; Cerinic MM; Cimaz R; Zulian F Lupus; 2009 Feb; 18(2):139-43. PubMed ID: 19151115 [TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis. Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525 [TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis. Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157 [TBL] [Abstract][Full Text] [Related]
4. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus. Dittrich K; Ross S; Benz K; Amann K; Dötsch J Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565 [TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center. Lourdudoss C; Vollenhoven Rv Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811 [TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis. Kazderova M; Jancova E; Rysava R; Merta M; Tesar V Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004 [TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine. Fu YF; Liu GL Clin Nephrol; 2001 Apr; 55(4):318-21. PubMed ID: 11334319 [TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil treatment in children and adolescents with lupus. Kazyra I; Pilkington C; Marks SD; Tullus K Arch Dis Child; 2010 Dec; 95(12):1059-61. PubMed ID: 20810399 [TBL] [Abstract][Full Text] [Related]
11. Current therapies for lupus nephritis in an ethnically heterogeneous cohort. Rivera TL; Belmont HM; Malani S; Latorre M; Benton L; Weisstuch J; Barisoni L; Tseng CE; Izmirly PM; Buyon JP; Askanase AD J Rheumatol; 2009 Feb; 36(2):298-305. PubMed ID: 19040310 [TBL] [Abstract][Full Text] [Related]
12. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis. F L; Y T; X P; L W; H W; Z S; H Z; Z H; Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634 [TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. Buratti S; Szer IS; Spencer CH; Bartosh S; Reiff A J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982 [TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil for remission induction in severe lupus nephritis. Cross J; Dwomoa A; Andrews P; Burns A; Gordon C; Main J; Mathieson P; O'Donoghue D; Jayne D; Nephron Clin Pract; 2005; 100(3):c92-100. PubMed ID: 15824513 [TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Glicklich D; Acharya A Am J Kidney Dis; 1998 Aug; 32(2):318-22. PubMed ID: 9708620 [TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Mycophenolate Mofetil for the Treatment of Juvenile-Onset Proliferative Lupus Nephritis. Tian SY; Silverman ED; Pullenayegum E; Brown PE; Beyene J; Feldman BM Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1887-1894. PubMed ID: 28182833 [TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. Hu W; Liu Z; Chen H; Tang Z; Wang Q; Shen K; Li L Chin Med J (Engl); 2002 May; 115(5):705-9. PubMed ID: 12133539 [TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil in lupus glomerulonephritis: effectiveness and tolerability. Iaccarino L; Arienti S; Rampudda M; Canova M; Atzeni F; Sarzi Puttini P; Doria A Ann N Y Acad Sci; 2007 Sep; 1110():516-24. PubMed ID: 17911467 [TBL] [Abstract][Full Text] [Related]
19. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study. Tselios K; Gladman DD; Su J; Urowitz MB J Rheumatol; 2016 Mar; 43(3):552-8. PubMed ID: 26773121 [TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature. Conti F; Ceccarelli F; Perricone C; Massaro L; Cipriano E; Pacucci VA; Truglia S; Miranda F; Morello F; Alessandri C; Spinelli FR; Valesini G Immunol Res; 2014 Dec; 60(2-3):270-6. PubMed ID: 25468307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]